View Future GrowthBrederode 과거 순이익 실적과거 기준 점검 2/6Brederode의 수입은 연평균 -33%의 비율로 감소해 온 반면, Capital Markets 산업은 수입이 연평균 1% 증가했습니다. 매출은 연평균 36.3%의 비율로 감소해 왔습니다. Brederode의 자기자본이익률은 2.9%이고 순이익률은 140.1%입니다.핵심 정보-32.96%순이익 성장률-32.96%주당순이익(EPS) 성장률Capital Markets 산업 성장률14.66%매출 성장률-36.33%자기자본이익률2.94%순이익률140.12%다음 순이익 업데이트11 Jun 2026최근 과거 실적 업데이트공시 • Jan 09+ 3 more updatesBrederode SA to Report First Half, 2026 Results on Sep 10, 2026Brederode SA announced that they will report first half, 2026 results on Sep 10, 2026공시 • Dec 06+ 3 more updatesBrederode SA to Report Nine Months, 2025 Results on Dec 11, 2025Brederode SA announced that they will report nine months, 2025 results on Dec 11, 2025공시 • Dec 13+ 4 more updatesBrederode SA to Report Q3, 2024 Results on Dec 05, 2024Brederode SA announced that they will report Q3, 2024 results on Dec 05, 2024공시 • Dec 21+ 3 more updatesBrederode SA to Report First Half, 2023 Results on Sep 14, 2023Brederode SA announced that they will report first half, 2023 results on Sep 14, 2023모든 업데이트 보기Recent updatesBuy Or Sell Opportunity • Feb 25Now 21% overvaluedOver the last 90 days, the stock has fallen 1.5% to €105. The fair value is estimated to be €87.07, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 16%.공시 • Jan 09+ 3 more updatesBrederode SA to Report First Half, 2026 Results on Sep 10, 2026Brederode SA announced that they will report first half, 2026 results on Sep 10, 2026공시 • Dec 06+ 3 more updatesBrederode SA to Report Nine Months, 2025 Results on Dec 11, 2025Brederode SA announced that they will report nine months, 2025 results on Dec 11, 2025Buy Or Sell Opportunity • Dec 05Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.5% to €104. The fair value is estimated to be €130, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.Buy Or Sell Opportunity • Nov 12Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at €105. The fair value is estimated to be €132, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.Buy Or Sell Opportunity • Oct 23Now 20% undervaluedOver the last 90 days, the stock has risen 1.8% to €110. The fair value is estimated to be €139, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.Buy Or Sell Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.6% to €112. The fair value is estimated to be €140, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.공시 • Dec 13+ 4 more updatesBrederode SA to Report Q3, 2024 Results on Dec 05, 2024Brederode SA announced that they will report Q3, 2024 results on Dec 05, 2024Buying Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.9%. The fair value is estimated to be €118, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Earnings per share has declined by 24%.New Risk • Aug 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risk Shareholders have been diluted in the past year (4.3% increase in shares outstanding).공시 • Dec 21+ 3 more updatesBrederode SA to Report First Half, 2023 Results on Sep 14, 2023Brederode SA announced that they will report first half, 2023 results on Sep 14, 2023Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €97.50, the stock trades at a trailing P/E ratio of 2.6x. Average trailing P/E is 11x in the Capital Markets industry in Europe. Total returns to shareholders of 62% over the past three years.Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Is New 90 Day High Low • Mar 11New 90-day high: €88.20The company is up 10.0% from its price of €80.50 on 11 December 2020. The Luxembourger market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 9.0% over the same period.Is New 90 Day High Low • Jan 23New 90-day high: €85.00The company is up 13% from its price of €75.00 on 23 October 2020. The Luxembourger market is up 7.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Capital Markets industry, which is up 17% over the same period.Is New 90 Day High Low • Nov 27New 90-day high: €80.00The company is up 6.0% from its price of €75.30 on 28 August 2020. The Luxembourger market is up 9.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is up 5.0% over the same period.Is New 90 Day High Low • Oct 29New 90-day low: €71.80The company is down 4.0% from its price of €74.50 on 30 July 2020. The Luxembourger market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 5.0% over the same period.Is New 90 Day High Low • Sep 29New 90-day high: €78.50The company is up 5.0% from its price of €74.60 on 01 July 2020. The Luxembourger market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 1.0% over the same period.매출 및 비용 세부 내역Brederode가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이BDL:BREL 매출, 비용 및 순이익 (EUR Millions)날짜매출순이익일반관리비연구개발비31 Dec 25891240030 Sep 2552870030 Jun 2514500031 Mar 251962320031 Dec 243774130030 Sep 243063430030 Jun 242362720031 Mar 242202530031 Dec 232052340030 Sep 231711990030 Jun 231371650031 Mar 2317460031 Dec 22-103-730030 Sep 221211510030 Jun 223453750031 Mar 226747050031 Dec 211,0041,0360030 Sep 219329640030 Jun 218608920031 Mar 215465770031 Dec 202322620030 Sep 201832130030 Jun 201351650031 Mar 202823110031 Dec 194304580030 Sep 193563840030 Jun 192823100031 Mar 192202460031 Dec 181571820030 Sep 181752000030 Jun 181932180031 Mar 181701940031 Dec 171471700030 Sep 171802030030 Jun 172142370031 Mar 171932040031 Dec 161721720030 Sep 161221221030 Jun 1673722031 Mar 161511482031 Dec 152292242030 Sep 152522483030 Jun 1527627200양질의 수익: BREL는 고품질 수익을 보유하고 있습니다.이익 마진 증가: BREL의 현재 순 이익률 은 지난해 보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: BREL의 수익은 지난 5년 동안 연평균 33% 감소했습니다.성장 가속화: BREL은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.수익 대 산업: BREL은 지난 1년 동안 수익이 감소(-69.9%)하여 Capital Markets 업계 평균(19.6%)과 비교하기 어렵습니다.자기자본이익률높은 ROE: BREL의 자본 수익률(2.9%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YDiversified-financials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/24 23:16종가2026/05/22 00:00수익2025/12/31연간 수익2025/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Brederode SA는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Jan 09+ 3 more updatesBrederode SA to Report First Half, 2026 Results on Sep 10, 2026Brederode SA announced that they will report first half, 2026 results on Sep 10, 2026
공시 • Dec 06+ 3 more updatesBrederode SA to Report Nine Months, 2025 Results on Dec 11, 2025Brederode SA announced that they will report nine months, 2025 results on Dec 11, 2025
공시 • Dec 13+ 4 more updatesBrederode SA to Report Q3, 2024 Results on Dec 05, 2024Brederode SA announced that they will report Q3, 2024 results on Dec 05, 2024
공시 • Dec 21+ 3 more updatesBrederode SA to Report First Half, 2023 Results on Sep 14, 2023Brederode SA announced that they will report first half, 2023 results on Sep 14, 2023
Buy Or Sell Opportunity • Feb 25Now 21% overvaluedOver the last 90 days, the stock has fallen 1.5% to €105. The fair value is estimated to be €87.07, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 17% over the last 3 years. Earnings per share has grown by 16%.
공시 • Jan 09+ 3 more updatesBrederode SA to Report First Half, 2026 Results on Sep 10, 2026Brederode SA announced that they will report first half, 2026 results on Sep 10, 2026
공시 • Dec 06+ 3 more updatesBrederode SA to Report Nine Months, 2025 Results on Dec 11, 2025Brederode SA announced that they will report nine months, 2025 results on Dec 11, 2025
Buy Or Sell Opportunity • Dec 05Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.5% to €104. The fair value is estimated to be €130, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
Buy Or Sell Opportunity • Nov 12Now 20% undervaluedThe stock has been flat over the last 90 days, currently trading at €105. The fair value is estimated to be €132, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
Buy Or Sell Opportunity • Oct 23Now 20% undervaluedOver the last 90 days, the stock has risen 1.8% to €110. The fair value is estimated to be €139, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
Buy Or Sell Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 1.6% to €112. The fair value is estimated to be €140, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 71% over the last 3 years. Earnings per share has declined by 67%.
공시 • Dec 13+ 4 more updatesBrederode SA to Report Q3, 2024 Results on Dec 05, 2024Brederode SA announced that they will report Q3, 2024 results on Dec 05, 2024
Buying Opportunity • Oct 02Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 6.9%. The fair value is estimated to be €118, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 26% over the last 3 years. Earnings per share has declined by 24%.
New Risk • Aug 07New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 4.3% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk Revenue is less than US$1m. Minor Risk Shareholders have been diluted in the past year (4.3% increase in shares outstanding).
공시 • Dec 21+ 3 more updatesBrederode SA to Report First Half, 2023 Results on Sep 14, 2023Brederode SA announced that they will report first half, 2023 results on Sep 14, 2023
Board Change • Nov 16Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Valuation Update With 7 Day Price Move • May 25Investor sentiment deteriorated over the past weekAfter last week's 16% share price decline to €97.50, the stock trades at a trailing P/E ratio of 2.6x. Average trailing P/E is 11x in the Capital Markets industry in Europe. Total returns to shareholders of 62% over the past three years.
Board Change • Apr 27Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Non Executive Director René Beltjens was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Is New 90 Day High Low • Mar 11New 90-day high: €88.20The company is up 10.0% from its price of €80.50 on 11 December 2020. The Luxembourger market is down 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Jan 23New 90-day high: €85.00The company is up 13% from its price of €75.00 on 23 October 2020. The Luxembourger market is up 7.0% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Capital Markets industry, which is up 17% over the same period.
Is New 90 Day High Low • Nov 27New 90-day high: €80.00The company is up 6.0% from its price of €75.30 on 28 August 2020. The Luxembourger market is up 9.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Capital Markets industry, which is up 5.0% over the same period.
Is New 90 Day High Low • Oct 29New 90-day low: €71.80The company is down 4.0% from its price of €74.50 on 30 July 2020. The Luxembourger market is down 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 5.0% over the same period.
Is New 90 Day High Low • Sep 29New 90-day high: €78.50The company is up 5.0% from its price of €74.60 on 01 July 2020. The Luxembourger market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Capital Markets industry, which is down 1.0% over the same period.